GEPL’s Pick of the Week


GEPL’s pick of the week is Indoco Remedies Ltd recommended at the price of Rs 505 and a target of Rs 750 over the next 12 months. Indoco is one of the fastest growing pharma companies manufacturing finished dosage forms and API aptly placed to tap the huge opportunity visible in the generic space. It is strongly placed in the domestic space that contributes around 70% of the revenues. The Company is undertaking expansions across its different business segments which should further help it cater to increasing demand. The company has entered into dossier and licensing deals with Watson and Aspen Pharmacare with a gradual ramp up in the deal size placing the company in a better position to cater to a wider range of markets. These would be the key growth drivers for the company once the approvals and regulatory issues are in place. Thus, with the organic growth being intact and increasing business through alliances with MNC’s we stand positive on the company and recommend a BUY on the stock.


Click here to start investing now

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s